Free Trial
OTCMKTS:GBLX

GB Sciences (GBLX) Stock Price, News & Analysis

GB Sciences logo
$0.0001 0.00 (0.00%)
As of 11/4/2026 03:59 PM Eastern

About GB Sciences Stock (OTCMKTS:GBLX)

Advanced

Key Stats

Today's Range
$0.0001
▼
$0.0001
50-Day Range
N/A
52-Week Range
$0.0001
▼
$0.0030
Volume
43,250 shs
Average Volume
41,606 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GB Sciences, Inc. (OTCMKTS: GBLX) is a biotechnology company focused on developing cannabis-based medicines and therapeutic products. Its work has centered on identifying and formulating specific combinations of cannabinoids and other plant compounds for potential use in treating medical conditions.

The company has historically pursued research programs involving conditions such as Parkinson’s disease, chronic pain, anxiety and other neurological or inflammatory disorders. Its activities have included cannabis cultivation and processing initiatives, as well as the development of standardized extracts and formulations intended for pharmaceutical and wellness applications.

GB Sciences has operated primarily in the United States, with historical activities connected to cannabis markets and research partnerships in states including Louisiana and Nevada. Publicly available information about its current operations, leadership team and commercial product portfolio is limited and may have changed over time.

AI Generated. May Contain Errors.

Receive GBLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GB Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GBLX Stock News Headlines

GB Sciences Inc.
GB Sciences Delays Filing of Quarterly Report
This little-known fund tracks gold and pays out weekly
A little-known $15 fund tied to gold could pay you cash every Friday, no mining stock required. In one recent month, those payments added up to $1,127, without the risks of management decisions or rising mining costs.tc pixel
GB Sciences Delays Filing of Quarterly Report
GB Sciences, Inc. (GBLX) - Yahoo Finance
GB Sciences Reports Delay in Quarterly Filing
GB Sciences, Inc. (GBLX) stock forecast and price target
GB Sciences Inc (GBLX)
See More Headlines

GBLX Stock Analysis - Frequently Asked Questions

GB Sciences' stock was trading at $0.0005 at the beginning of the year. Since then, GBLX shares have decreased by 80.0% and is now trading at $0.0001.

GB Sciences, Inc. (OTCMKTS:GBLX) released its quarterly earnings data on Monday, November, 14th. The company reported ($0.04) EPS for the quarter.

Shares of GBLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GB Sciences investors own include TREES (CANN), Unrivaled Brands (TRTC), Canopy Growth (CGC), Medical Marijuana (MJNA), Aurora Cannabis (ACBFF), Aurora Cannabis (ACB) and 22nd Century Group (XXII).

Company Calendar

Last Earnings
11/14/2016
Today
11/05/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:GBLX
CIK
1165320
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (OTCMKTS:GBLX) was last updated on 11/4/2026 by MarketBeat.com Staff.
From Our Partners